Evidence map›Paper›PMID 26312689›Full record

ArticleAnais brasileiros de dermatologia

Post-kala-azar dermal Leishmaniasis in two different clinical contexts.

Daniel Holanda Barroso, Claúdia Elise Ferraz Silva, Ana Carolina Depes Perdigao e Vasconcelos, Silvana Maria de Morais Cavalcanti, Maria Edileuza Felinto de Brito, Angela Cristina Rapela Medeiros

Abstract readCase Reports
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel Holanda BarrosoUniversidade de Pernambuco, Recife, PE, BR.
Claúdia Elise Ferraz SilvaUniversidade Federal de Pernambuco, Recife, PE, BR.
Ana Carolina Depes Perdigao e VasconcelosUniversidade de Pernambuco, Recife, PE, BR.
Silvana Maria de Morais CavalcantiUniversidade de Pernambuco, Recife, PE, BR.
Maria Edileuza Felinto de BritoFundação Oswaldo Cruz, Recife, PE, BR.
Angela Cristina Rapela MedeirosUniversidade de Pernambuco, Recife, PE, BR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Brazil, visceral Leishmaniasis is caused by Leishmania chagasi. The development of cutaneous lesions in visceral leishmaniasis patients has been described in two different clinical contexts. Patients with compromised immunity can develop skin lesions as a direct consequence of a current visceral disease. Equally, patients with a history of kala-azar and progressive, immune improvement occasionally develop skin lesions as a consequence of immune reconstitution inflammatory syndrome. These cases manifest in similar fashion to the classic form of post-kala-azar dermal Leishmaniasis. We describe different cases that exemplify these two clinical presentations.

Indexed as

AdultAIDS-Related Opportunistic InfectionsAmphotericin BAntiprotozoal AgentsAntiretroviral Therapy, Highly ActiveHIV InfectionsHumansLeishmaniasis, CutaneousLeishmaniasis, VisceralMaleAmphotericin BAntiprotozoal Agents

Identifiers

PMID26312689
PMCPMC4540523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.